Chemical and Genetic Effects of the Experimental Anti-Cancer Drugs in Cheek Cells in Cancer Patients
NCT00055380 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 120
Last updated 2008-03-04
Summary
This study will examine the effects of certain investigational anti-cancer drugs on the genetic and protein makeup of cells. The findings will be entered into a database that may be used to: 1) determine the optimal dose of drug that will provide the most benefit with the least harmful side effects; and 2) predict which patients will have a greater chance of developing side effects or a greater chance of benefiting from the drug.
Patients 18 years of age and older who are receiving the anti-cancer drugs flavopiridol or perifosine in an NIH clinical trial may be eligible for this study.
Participants will undergo the following procedures both before starting treatment and during the first treatment cycle to look for genetic or chemical changes produced in response to the study drug:
* Blood draws.
* Buccal cell brushings: Collection of buccal cells (cells lining the inside of the cheeks) from the inside of the cheeks using a soft bristle brush for a few seconds several times. The patient then rinses the mouth with salt water for 1 minute and then spits into a cup.
* Buccal cell biopsies (on both sides of the mouth): For this procedure, a local anesthetic is given to numb the biopsy area. Then, a small piece of tissue from the inner lining of the mouth is removed with a small sharp cookie-cutter instrument. The biopsy findings will be compared with those of the cheek brushings to see if the information is similar.
* Tumor biopsies: In patients whose tumor is easily accessible, such as the skin abdominal fluid, tissue biopsies will be requested. Depending on the type and location of the tumor, the biopsy may be done with a forceps, a large needle (needle biopsy), a cookie-cutter instrument (punch biopsy), or a small knife (excisional biopsy). All of these procedures are done with a local anesthetic.
Conditions
Interventions
- PROCEDURE
-
Oral cytobrushing
Sponsors & Collaborators
-
National Institute of Dental and Craniofacial Research (NIDCR)
lead NIH
Study Design
- Purpose
- TREATMENT
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2003-02-28
- Completion
- 2005-10-31
Countries
- United States
Study Locations
More Related Trials
-
RRx-001 for Reducing Oral Mucositis in Patients Receiving Chemotherapy and Radiation for Head and Neck Cancer
NCT05966194 ·Status: RECRUITING ·Phase: PHASE2
-
Tobacco and Alcohol Influence on Oncogenic Drivers and Somatic Evolution in the Oral Mucosa
NCT06094829 ·Status: COMPLETED
-
Evaluation of ONCOXIN® in Oral Mucositis, Appetite and Body Mass in Cancer Patients.
NCT03577535 ·Status: COMPLETED ·Phase: PHASE2
-
Chemoprevention Study of Oral Cavity Squamous Cell Carcinoma
NCT00201279 ·Status: COMPLETED ·Phase: PHASE3
-
Head and Neck Cancer Patients With Oral Mucositis Treated With Ketamine Oral Rinse
NCT06660017 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Observational Study of Anti-Cancer Therapy Induced Oral Mucositis in Korean Cancer Patients
NCT00549952 ·Status: UNKNOWN
-
Treatment of Severe Mucositis Pain With Oral Ketamine Mouthwash
NCT01566448 ·Status: COMPLETED ·Phase: PHASE2
-
Prevalence of Oral Side Effects Associated With Chemo and Radiotherapy for Treating Head and Neck Cancer
NCT04845854 ·Status: COMPLETED
-
Dose Ranging Study to Assess the Safety and Efficacy of SCV-07 for the Delay to Onset of Severe Oral Mucositis in Patients Receiving Chemoradiation Therapy for Head and Neck Cancer
NCT00756951 ·Status: COMPLETED ·Phase: PHASE2
-
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
NCT06532279 ·Status: RECRUITING ·Phase: PHASE2
-
Clinical and Molecular Features of Oral Premalignancy and Oral Cancer
NCT06550050 ·Status: RECRUITING
-
Evaluating Chinese Medicine Oral Rinse for Irradiated Oral Mucositis in Head & Neck Cancer Patients
NCT05664906 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Analgesic Effects of Topical Ketamine Mouthwash in Patients Receiving Chemoradiation or Radiotherapy for Head & Neck Cancer
NCT01653327 ·Status: COMPLETED ·Phase: PHASE2
-
Incidence and Factors Associated With the Development and Severity of Oral Mucositis
NCT00575809 ·Status: COMPLETED
-
To Check Safety of Ayurvedic Oral Cannabis in Breast and Head and Neck Cancer
NCT05969314 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Safety and Efficacy of RRx-001 in the Attenuation of Oral Mucositis in Patients Receiving Chemoradiation for the Treatment of Oral Cancers
NCT03515538 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of the Effects of GC4419 on Radiation Induced Oral Mucositis in Patients With Head/Neck Cancer
NCT02508389 ·Status: COMPLETED ·Phase: PHASE2
-
EN3285 for the Prevention or Delay of Oral Mucositis in Patients With Head and Neck Cancer
NCT00574860 ·Status: TERMINATED ·Phase: PHASE3
-
Submandibular Gland Stem Cell Transplantation
NCT04593589 ·Status: RECRUITING ·Phase: PHASE1
-
Safety and Efficacy of ALD518 for Reducing Oral Mucositis in Head and Neck Cancer Subjects
NCT01403064 ·Status: TERMINATED ·Phase: PHASE2
-
L-lysine in Treating Oral Mucositis in Patients Undergoing Radiation Therapy With or Without Chemotherapy For Head and Neck Cancer
NCT01155609 ·Status: COMPLETED ·Phase: NA
-
Clinical Evaluation of Bioadhesive Gels for Oral Cancer Chemoprevention
NCT01192204 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Comparison of Transdermal Fentanyl and Morphine for Oral Mucositis Pain in Nasopharyngeal Cancer Patients
NCT04292990 ·Status: UNKNOWN ·Phase: PHASE4
-
Autofluorescence Detection of Oral Malignancies and Database and Biospecimen Collection to Identify Biomarkers of Head and Neck Tumor Progression
NCT01531881 ·Status: COMPLETED
-
Wild Type p53 Adenovirus for Oral Premalignancies
NCT00410865 ·Status: TERMINATED ·Phase: PHASE1